ITF Pharma Announces Availability Of TIGLUTIK™ (riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS) In The United States
Biospace,
BERWYN, Pa., /PRNewswire/ -- ITF Pharma, a U.S.-based specialty pharmaceutical company and a subsidiary of Italfarmaco, a…